Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer - Contacts and Locations

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

This study is ongoing, but not recruiting participants.

Study NCT00036790. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00036790

Locations


United States, Pennsylvania
	Hillman Cancer Center at University of Pittsburgh Cancer Institute
	Pittsburgh, Pennsylvania, United States, 15232

United States, Wisconsin
	University of Wisconsin Comprehensive Cancer Center
	Madison, Wisconsin, United States, 53792

Sponsors and Collaborators

University of Wisconsin, Madison

National Cancer Institute (NCI)

Investigators


Study Chair:	Markus Renschler, MD	Pharmacyclics